Learn More
Human TCF-3/E2A Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | TCF-3/E2A |
| Applications | Immunocytochemistry |
| Classification | Monoclonal |
| Clone | 401709 |
| Concentration | LYOPH |
| Conjugate | Unconjugated |
| Dilution | Immunocytochemistry 8-25 ug/mL |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative |
| Gene Accession No. | NP_003191 |
| Gene Alias | BHLHB21, bHLHb21TCF-3, Class B basic helix-loop-helix protein 21, E2A, E2A immunoglobulin enhancer-binding factor E12/E47, E2AKappa-E2-binding factor, Immunoglobulin enhancer-binding factor E12/E47, Immunoglobulin transcription factor 1, ITF1, ITF1Transcription factor ITF-1, Kappa-E2-binding factor, MGC129647, MGC129648, Pan2, Tcfe2a, Transcription factor 3, transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47), transcription factor E2-alpha, VDIR, VDR interacting repressor |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.